These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9420451)
1. How grapefruit juice potentiates drug bioavailability. Feldman EB Nutr Rev; 1997 Nov; 55(11 Pt 1):398-400. PubMed ID: 9420451 [TBL] [Abstract][Full Text] [Related]
2. Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. Bailey DG; Kreeft JH; Munoz C; Freeman DJ; Bend JR Clin Pharmacol Ther; 1998 Sep; 64(3):248-56. PubMed ID: 9757148 [TBL] [Abstract][Full Text] [Related]
3. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Lundahl J; Regårdh CG; Edgar B; Johnsson G Eur J Clin Pharmacol; 1995; 49(1-2):61-7. PubMed ID: 8751023 [TBL] [Abstract][Full Text] [Related]
4. Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Lundahl J; Regårdh CG; Edgar B; Johnsson G Eur J Clin Pharmacol; 1997; 52(2):139-45. PubMed ID: 9174684 [TBL] [Abstract][Full Text] [Related]
5. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Bailey DG; Dresser GK; Bend JR Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362 [TBL] [Abstract][Full Text] [Related]
7. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Bailey DG; Bend JR; Arnold JM; Tran LT; Spence JD Clin Pharmacol Ther; 1996 Jul; 60(1):25-33. PubMed ID: 8689808 [TBL] [Abstract][Full Text] [Related]
8. The interaction effect of grapefruit juice is maximal after the first glass. Lundahl JU; Regårdh CG; Edgar B; Johnsson G Eur J Clin Pharmacol; 1998 Mar; 54(1):75-81. PubMed ID: 9591935 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model. Takanaga H; Ohnishi A; Matsuo H; Murakami H; Sata H; Kuroda K; Urae A; Higuchi S; Sawada Y Br J Clin Pharmacol; 2000 Jan; 49(1):49-58. PubMed ID: 10606837 [TBL] [Abstract][Full Text] [Related]
10. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299 [TBL] [Abstract][Full Text] [Related]
12. Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans. Goosen TC; Cillié D; Bailey DG; Yu C; He K; Hollenberg PF; Woster PM; Cohen L; Williams JA; Rheeders M; Dijkstra HP Clin Pharmacol Ther; 2004 Dec; 76(6):607-17. PubMed ID: 15592332 [TBL] [Abstract][Full Text] [Related]
13. Interaction of grapefruit juice and calcium channel blockers. Sica DA Am J Hypertens; 2006 Jul; 19(7):768-73. PubMed ID: 16814135 [TBL] [Abstract][Full Text] [Related]
14. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Fuhr U Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737 [TBL] [Abstract][Full Text] [Related]